Blog
RSS FeedPosted by Michael Wonder on 30 Aug 2022
First new kidney treatment in 20 years delays dialysis and transplant
31 August 2022 - Kidney disease is Australia’s silent killer, with nine in 10 patients unaware they have it until too ...
Posted by Michael Wonder on 28 Aug 2022
Ovarian cancer drug that costs up to $130k will soon be affordable for hundreds of patients
28 August 2022 - A drug that works to prolong survival for some patients with advanced ovarian cancer is being ...
Posted by Michael Wonder on 01 Aug 2022
PBS listings will help people with spinal muscular atrophy, schizophrenia and multiple sclerosis
1 August 2022 - From today, Australians will have access to new and updated PBS listings, including a new spinal ...
Posted by Michael Wonder on 31 Jul 2022
Schedule of Pharmaceutical Benefits - 1 August 2022
1 August 2022 - The August 2022 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...
Posted by Michael Wonder on 31 Jul 2022
New Zealand Pharmaceutical Schedule - 1 August 2022
1 August 2022 - The August 2022 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 01 Jul 2022
New PBS listings from 1 July 2022
1 July 2022 - Vitrakvi (larotrectinib) will list for the first time for the treatment of adult and paediatric patients with ...
Posted by Michael Wonder on 30 Jun 2022
PBS listing for ‘Australian success story’ blood cancer drug
1 July 2022 - A pill that removes the need for chemotherapy for some cancer sufferers has been put on ...
Posted by Michael Wonder on 30 Jun 2022
Schedule of Pharmaceutical Benefits - 1 July 2022
1 July 2022 - The July 2022 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...
Posted by Michael Wonder on 31 May 2022
Schedule of Pharmaceutical Benefits - 1 June 2022
1 June 2022 - The June 2022 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...
Posted by Michael Wonder on 31 May 2022
New Zealand Pharmaceutical Schedule - 1 June 2022
1 June 2022 - The June 2022 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 26 May 2022
Janssen’s psoriatic arthritis drug Tremfya gets insurance coverage
26 May 2022 - Janssen Korea said that the Ministry of Health and Welfare would begin to reimburse Tremfya, its ...
Posted by Michael Wonder on 19 May 2022
BMS’ Sprycel reimbursement criteria to be broadened for paediatric Philadelphia chromosome positive ALL
19 May 2022 - The state health insurance review agency said it would broaden the reimbursement criteria for Sprycel (dasatinib), ...
Posted by Michael Wonder on 16 May 2022
Spravato approved for reimbursement in Ireland for adults with treatment-resistant major depressive disorder
16 May 2022 - Janssen has announced that Spravato (esketamine) nasal spray has been granted reimbursement in Ireland for the ...
Posted by Michael Wonder on 10 May 2022
Fertility drug Rekovelle gets reimbursable in combo with hMG
10 May 2022 - Ferring’s Rekovelle (follitropin delta), a treatment to promote egg production in ovaries, became reimbursable when used ...
Posted by Michael Wonder on 03 May 2022
First million dollar medicine listed on the PBS
4 May 2022 - Zolgensma has the great honour of being the first medicine listed on the PBS with a ...